These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20816581)

  • 1. Heritability of hematologic malignancies: from pedigrees to genomics.
    Churpek JE; Onel K
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):939-72. PubMed ID: 20816581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
    Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K
    PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discussing and managing hematologic germ line variants.
    Kohlmann W; Schiffman JD
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
    Mangaonkar AA; Patnaik MM
    Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging cancer genome information in hematologic malignancies.
    Rampal R; Levine RL
    J Clin Oncol; 2013 May; 31(15):1885-92. PubMed ID: 23589554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposition to pediatric and hematologic cancers: a moving target.
    Malkin D; Nichols KE; Zelley K; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic testing in myeloid malignancy.
    Docking TR; Karsan A
    Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
    Trottier AM; Godley LA
    Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary myeloid malignancies.
    Rafei H; DiNardo CD
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.
    Ansar S; Malcolmson J; Farncombe KM; Yee K; Kim RH; Sibai H
    Genet Med; 2022 Nov; 24(11):2367-2379. PubMed ID: 36112138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary cancer predisposition syndromes.
    Gallagher DJ; Feifer A; Coleman JA
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):861-83. PubMed ID: 20816578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussing and managing hematologic germ line variants.
    Kohlmann W; Schiffman JD
    Blood; 2016 Nov; 128(21):2497-2503. PubMed ID: 27881370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of hereditary hematological malignancies].
    Takagi M
    Rinsho Ketsueki; 2015 Oct; 56(10):1969-77. PubMed ID: 26458435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Genetic Predisposition to Hematologic Malignancy.
    Furutani E; Shimamura A
    J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
    Friend P; Mahon SM
    Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
    Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
    Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.